Christopher Bayly, Ph.D.

Dr. Bayly brings more than 30 years of experience in the use of computational chemistry methods to solve practical pharmaceutical discovery problems, encompassing a unique combination of expertise in methods development and the application to drug discovery. While at OpenEye Cadence Molecular Sciences, Dr. Bayly led the introduction and development of Binding Free Energy methods, and he is also a co-founder and advisor to the Open Force Field Initiative, a broad-based collaboration to develop next-generation small molecule and biomolecular force fields. Prior to his time at OpenEye, Dr. Bayly founded and led the computational chemistry group at Merck Frosst for 18 years. Dr. Bayly earned a B.Sc. in biochemistry from Bishop’s University, an M.Sc. in synthetic bioorganic chemistry from L’Universite de Sherbrooke, and a Ph.D. in theoretical chemistry from the University of New Brunswick, followed by a postdoctoral term with Peter Kollman at the University of California, San Francisco.